Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Aleve
2. Anaprox
3. Methoxypropiocin
4. Naprosin
5. Naprosyn
6. Naproxen
7. Naproxenate, Sodium
8. Proxen
9. Sodium Naproxenate
10. Sodium, Naproxen
11. Synflex
1. 26159-34-2
2. Naprelan
3. Anaprox
4. Naproxen Sodium Salt
5. Miranax
6. (-)-naproxen Sodium
7. Aleve
8. Naproxen (sodium)
9. Naprium
10. Naprux
11. Proxen
12. Sodium (s)-2-(6-methoxynaphthalen-2-yl)propanoate
13. Bayh6689
14. Apo-napro-na
15. (s)-naproxen Sodium Salt
16. Sodium Naproxen
17. Rs-3650
18. Naproxen Sodium Anhydrous
19. Mls000069555
20. 9tn87s3a3c
21. Chebi:7477
22. (-)-sodium (s)-6-methoxy-alpha-methyl-2-naphthaleneacetate
23. 2-naphthaleneacetic Acid, 6-methoxy-alpha-methyl-, Sodium Salt, (s)-
24. Bay117031
25. Sodium;(2s)-2-(6-methoxynaphthalen-2-yl)propanoate
26. Bay-117031
27. Ncgc00017097-01
28. Anapran
29. Anaprotab
30. Aprowell
31. Floginex
32. Flogogin
33. Floneks
34. Floxalin
35. Gibinap
36. Gibixen
37. Karoksen
38. Leniartril
39. Monarit
40. Naprodil
41. Naprodol
42. Naprovite
43. Natrioxen
44. Pactens
45. Primeral
46. Smr000058746
47. Sodimax
48. Synflex
49. Flogen
50. Kapnax
51. Opraks
52. Tandax
53. (s)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid Sodium Salt
54. Aprol
55. Nixal
56. Cas-26159-34-2
57. Causalon Pro
58. Naproxen Natrium
59. Naprux Gesic
60. Axer Alfa
61. Dsstox_cid_25576
62. Dsstox_rid_80973
63. Dsstox_gsid_45576
64. Sodium (2s)-2-(6-methoxy-2-naphthyl)propanoate
65. A-nox
66. Anaprox Ds
67. Naproxensodium
68. Sunprox
69. Flanax
70. Naproxen Sodium [usan]
71. Einecs 247-486-2
72. Mfcd00058507
73. Unm-0000306098
74. Rs 3650
75. Topcare All Day Pain Relief
76. Unii-9tn87s3a3c
77. Naproxen Sodium [usan:usp]
78. Bay H6689
79. Naproxen (aleve)
80. Sodium (-)-2-(6-methoxy-2-naphthyl)propionate
81. Anaprox (tn)
82. Naproxen Sodium,(s)
83. Naproxen Sodium (usp)
84. L-(-)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid Sodium Salt
85. Opera_id_1200
86. Lopac-m-1275
87. Schembl7361
88. Mls001076076
89. Mls001424214
90. Naproxen Sodium [vandf]
91. Chembl1200806
92. Dtxsid7045576
93. Naproxen Sodium [mart.]
94. Naproxen Sodium [usp-rs]
95. Naproxen Sodium [who-dd]
96. Naproxen Sodium Salt [mi]
97. Hms1570o04
98. Hms2052g05
99. Hms2230d08
100. Hms3262o06
101. Hms3269j19
102. Hms3413p03
103. Hms3884g04
104. Tox21_110774
105. Tox21_500792
106. Hy-15030a
107. Naproxen Sodium, 98.0-102.0%
108. Naproxen Sodium [ep Impurity]
109. Naproxen Sodium [orange Book]
110. 2-naphthaleneacetic Acid, 6-methoxy-.alpha.-methyl-, Sodium Salt, (s)-
111. Akos015895696
112. Akos015994759
113. Naproxen Sodium [ep Monograph]
114. Naproxen Sodium [usp Impurity]
115. Tox21_110774_1
116. Bcp9000977
117. Ccg-101082
118. Ks-5141
119. Lp00792
120. Naproxen Sodium [usp Monograph]
121. 2-naphthaleneacetic Acid, 6-methoxy-alpha-methyl-, Sodium Salt, L-(-)-
122. Aleve-d Component Naproxen Sodium
123. Ncgc00016166-01
124. Ncgc00016759-04
125. Ncgc00017097-02
126. Ncgc00094127-01
127. Ncgc00261477-01
128. Treximet Component Naproxen Sodium
129. Bcp0726000300
130. Naproxen Sodium Component Of Aleve-d
131. Eu-0100792
132. M3406
133. Naproxen Sodium Component Of Treximet
134. S1626
135. Sw197105-3
136. 59n342
137. Bim-0050769.0001
138. D00970
139. M 1275
140. Sodium (s)-2-(6-methoxy-2-naphthyl)propionate
141. A818221
142. Naproxen Sodium, Meets Usp Testing Specifications
143. Sodium(s)-2-(6-methoxynaphthalen-2-yl)propanoate
144. W-107195
145. Q27107504
146. (2s)-2-(6-methoxy(2-naphthyl))propanoic Acid Sodium Salt
147. (2s)-2-(6-methoxy-2-naphthyl)propanoic Acid Sodium Salt
148. (s)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid Sodium
149. Naproxen Sodium, United States Pharmacopeia (usp) Reference Standard
150. 2-naphthaleneacetic Acid, 6-methoxy-.alpha.-methyl-, Sodium Salt, (.alpha.s)- (1:1)
151. Naproxen Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
| Molecular Weight | 252.24 g/mol |
|---|---|
| Molecular Formula | C14H13NaO3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 252.07623855 g/mol |
| Monoisotopic Mass | 252.07623855 g/mol |
| Topological Polar Surface Area | 49.4 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 282 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 12 | |
|---|---|
| Drug Name | Aleve |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 200mg base |
| Market Status | Over the Counter |
| Company | Bayer |
| 2 of 12 | |
|---|---|
| Drug Name | Anaprox |
| Drug Label | Naproxen is a proprionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory drugs.The chemical names for naproxen and naproxen sodium are (S)-6-methoxy--methyl-2-naphthaleneacetic acid and (S)-6-methoxy--methyl... |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 250mg base |
| Market Status | Prescription |
| Company | Hoffmann La Roche |
| 3 of 12 | |
|---|---|
| Drug Name | Anaprox ds |
| Drug Label | Naproxen is a proprionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory drugs.The chemical names for naproxen and naproxen sodium are (S)-6-methoxy--methyl-2-naphthaleneacetic acid and (S)-6-methoxy--methyl... |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 500mg base |
| Market Status | Prescription |
| Company | Hoffmann La Roche |
| 4 of 12 | |
|---|---|
| Drug Name | Naprelan |
| Drug Label | NAPRELAN* Tablets contain naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs). NAPRELAN Tablets use the proprietary IPDAS** (Intestinal Protective Drug Absorption System) technology. It is a r... |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | eq 750mg base; eq 500mg base; eq 375mg base |
| Market Status | Prescription |
| Company | Almatica Pharma |
| 5 of 12 | |
|---|---|
| Drug Name | Naprosyn |
| Drug Label | Naproxen is a proprionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory drugs.The chemical names for naproxen and naproxen sodium are (S)-6-methoxy--methyl-2-naphthaleneacetic acid and (S)-6-methoxy--methyl... |
| Active Ingredient | Naproxen |
| Dosage Form | Tablet; Suspension |
| Route | Oral |
| Strength | 250mg; 375mg; 500mg; 25mg/ml |
| Market Status | Prescription |
| Company | Roche Palo |
| 6 of 12 | |
|---|---|
| Drug Name | Naproxen sodium |
| Drug Label | NAPRELAN* Tablets contain naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs). NAPRELAN Tablets use the proprietary IPDAS** (Intestinal Protective Drug Absorption System) technology. It is a r... |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet, extended release; Tablet; Capsule |
| Route | Oral |
| Strength | eq 500mg base; eq 250mg base; eq 200mg base; eq 375mg base |
| Market Status | Over the Counter; Prescription |
| Company | Marksans Pharma; Actavis Labs Fl; Teva; Aurobindo Pharma; Banner Pharmacaps; Granules India; Hikma; Amneal Pharms Ny; Glenmark Generics; Perrigo; Contract Pharmacal; Ranbaxy Labs; Dr Reddys Labs |
| 7 of 12 | |
|---|---|
| Drug Name | Aleve |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 200mg base |
| Market Status | Over the Counter |
| Company | Bayer |
| 8 of 12 | |
|---|---|
| Drug Name | Anaprox |
| Drug Label | Naproxen is a proprionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory drugs.The chemical names for naproxen and naproxen sodium are (S)-6-methoxy--methyl-2-naphthaleneacetic acid and (S)-6-methoxy--methyl... |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 250mg base |
| Market Status | Prescription |
| Company | Hoffmann La Roche |
| 9 of 12 | |
|---|---|
| Drug Name | Anaprox ds |
| Drug Label | Naproxen is a proprionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory drugs.The chemical names for naproxen and naproxen sodium are (S)-6-methoxy--methyl-2-naphthaleneacetic acid and (S)-6-methoxy--methyl... |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 500mg base |
| Market Status | Prescription |
| Company | Hoffmann La Roche |
| 10 of 12 | |
|---|---|
| Drug Name | Naprelan |
| Drug Label | NAPRELAN* Tablets contain naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs). NAPRELAN Tablets use the proprietary IPDAS** (Intestinal Protective Drug Absorption System) technology. It is a r... |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | eq 750mg base; eq 500mg base; eq 375mg base |
| Market Status | Prescription |
| Company | Almatica Pharma |
| 11 of 12 | |
|---|---|
| Drug Name | Naprosyn |
| Drug Label | Naproxen is a proprionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory drugs.The chemical names for naproxen and naproxen sodium are (S)-6-methoxy--methyl-2-naphthaleneacetic acid and (S)-6-methoxy--methyl... |
| Active Ingredient | Naproxen |
| Dosage Form | Tablet; Suspension |
| Route | Oral |
| Strength | 250mg; 375mg; 500mg; 25mg/ml |
| Market Status | Prescription |
| Company | Roche Palo |
| 12 of 12 | |
|---|---|
| Drug Name | Naproxen sodium |
| Drug Label | NAPRELAN* Tablets contain naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs). NAPRELAN Tablets use the proprietary IPDAS** (Intestinal Protective Drug Absorption System) technology. It is a r... |
| Active Ingredient | Naproxen sodium |
| Dosage Form | Tablet, extended release; Tablet; Capsule |
| Route | Oral |
| Strength | eq 500mg base; eq 250mg base; eq 200mg base; eq 375mg base |
| Market Status | Over the Counter; Prescription |
| Company | Marksans Pharma; Actavis Labs Fl; Teva; Aurobindo Pharma; Banner Pharmacaps; Granules India; Hikma; Amneal Pharms Ny; Glenmark Generics; Perrigo; Contract Pharmacal; Ranbaxy Labs; Dr Reddys Labs |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Gout Suppressants
Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. (See all compounds classified as Gout Suppressants.)
API SUPPLIERS
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-03-26
Pay. Date : 2015-03-19
DMF Number : 3208
Submission : 1978-05-25
Status : Active
Type : II
Certificate Number : R1-CEP 2008-110 - Rev 01
Issue Date : 2015-06-10
Type : Chemical
Substance Number : 1702
Status : Valid
NDC Package Code : 30007-815
Start Marketing Date : 2012-02-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : SK Chemical Co., Ltd.
Registration Date : 2022-01-12
Registration Number : 20140318-143-I-360-09(3)
Manufacturer Name : Industrialas Quimicas Falcon de Mexico, SA De CV
Manufacturer Address : Km. 4.5, Carretera Federal Cuernavaca-Cuautla Col. CIVAC CP 62578 Mpio. Jiutepec, Morelos, Mexico
Pharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-30
Pay. Date : 2013-01-16
DMF Number : 12342
Submission : 1997-01-28
Status : Active
Type : II
Certificate Number : R1-CEP 2008-068 - Rev 03
Issue Date : 2019-06-21
Type : Chemical
Substance Number : 1702
Status : Valid
NDC Package Code : 55111-004
Start Marketing Date : 1997-01-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Hiple Co., Ltd.
Registration Date : 2019-12-31
Registration Number : 20140318-143-I-360-09(2)
Manufacturer Name : Industrialas Quimicas Falcon de Mexico, SA De CV
Manufacturer Address : Km. 4.5, Carretera Federal Cuernavaca-Cuautla Col. CIVAC CP 62578 Mpio. Jiutepec, Morelos, Mexico
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registrant Name : Pami Future Co., Ltd.
Registration Date : 2019-04-22
Registration Number : 20140318-143-I-360-09(1)
Manufacturer Name : Industrialas Quimicas Falcon de Mexico, SA De CV
Manufacturer Address : Km. 4.5, Carretera Federal Cuernavaca-Cuautla Col. CIVAC CP 62578 Mpio. Jiutepec, Morelos, Mexico
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registrant Name : Pami Future Co., Ltd.
Registration Date : 2014-03-18
Registration Number : 20140318-143-I-360-09
Manufacturer Name : Industrialas Quimicas Falcon de Mexico, SA De CV
Manufacturer Address : Km. 4.5, Carretera Federal Cuernavaca-Cuautla Col. CIVAC CP 62578 Mpio. Jiutepec, Morelos, Mexico
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37526
Submission : 2022-12-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12559
Submission : 1997-06-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16200
Submission : 2002-10-22
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-30
Pay. Date : 2013-01-16
DMF Number : 12342
Submission : 1997-01-28
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2015-03-26
Pay. Date : 2015-03-19
DMF Number : 3208
Submission : 1978-05-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7131
Submission : 1987-09-04
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11940
Submission : 1996-04-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8436
Submission : 1990-02-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6712
Submission : 1986-12-05
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11627
Submission : 1996-06-04
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-06-10
Pay. Date : 2015-05-28
DMF Number : 8746
Submission : 1990-09-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7456
Submission : 1988-04-21
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7569
Submission : 1988-07-13
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : R1-CEP 2008-068 - Rev 03
Status : Valid
Issue Date : 2019-06-21
Type : Chemical
Substance Number : 1702
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Naproxen Sodium, Cuernavaca, Mexico Site
Certificate Number : R1-CEP 2008-110 - Rev 01
Status : Valid
Issue Date : 2015-06-10
Type : Chemical
Substance Number : 1702
Certificate Number : R1-CEP 2009-085 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2015-11-10
Type : Chemical
Substance Number : 1702
Certificate Number : R1-CEP 2010-021 - Rev 01
Status : Valid
Issue Date : 2018-02-22
Type : Chemical
Substance Number : 1702
Certificate Number : R1-CEP 2007-110 - Rev 04
Status : Valid
Issue Date : 2021-10-21
Type : Chemical
Substance Number : 1702
Certificate Number : CEP 2022-389 - Rev 00
Status : Valid
Issue Date : 2024-09-13
Type : Chemical
Substance Number : 1702
Certificate Number : CEP 2022-443 - Rev 00
Status : Valid
Issue Date : 2024-11-26
Type : Chemical
Substance Number : 1702
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2007-047 - Rev 06
Status : Valid
Issue Date : 2025-03-17
Type : Chemical
Substance Number : 1702
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
Date of Issue : 2022-06-07
Valid Till : 2025-06-25
Written Confirmation Number : WC-0023
Address of the Firm : Survey no. 52,53,58,59,61 to 78,127&128, Pydibhimanvaram Village &Sy.No. 1,2,4t0...
Date of Issue : 2022-09-16
Valid Till : 2025-06-16
Written Confirmation Number : WC-0031
Address of the Firm : Unit-I, Lingojigudem Village, Choutuppal Mandal, Yadadri Bhuvanagiri District - ...
Date of Issue : 2022-06-03
Valid Till : 2025-06-16
Written Confirmation Number : WC-0030n
Address of the Firm : UNIT-II, Annavaram (Post), Chippada Village, Bheemunipatnam Mandai, Visakhapatna...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registrant Name : Hiple Co., Ltd.
Registration Date : 2019-12-31
Registration Number : 20140318-143-I-360-09(2)
Manufacturer Name : Industrialas Quimicas Falcon...
Manufacturer Address : Km. 4.5, Carretera Federal Cuernavaca-Cuautla Col. CIVAC CP 62578 Mpio. Jiutepec, Mor...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registrant Name : Pami Future Co., Ltd.
Registration Date : 2014-03-18
Registration Number : 20140318-143-I-360-09
Manufacturer Name : Industrialas Quimicas Falcon...
Manufacturer Address : Km. 4.5, Carretera Federal Cuernavaca-Cuautla Col. CIVAC CP 62578 Mpio. Jiutepec, Mor...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registrant Name : SK Chemical Co., Ltd.
Registration Date : 2022-01-12
Registration Number : 20140318-143-I-360-09(3)
Manufacturer Name : Industrialas Quimicas Falcon...
Manufacturer Address : Km. 4.5, Carretera Federal Cuernavaca-Cuautla Col. CIVAC CP 62578 Mpio. Jiutepec, Mor...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registrant Name : Pami Future Co., Ltd.
Registration Date : 2019-04-22
Registration Number : 20140318-143-I-360-09(1)
Manufacturer Name : Industrialas Quimicas Falcon...
Manufacturer Address : Km. 4.5, Carretera Federal Cuernavaca-Cuautla Col. CIVAC CP 62578 Mpio. Jiutepec, Mor...
Registrant Name : Hiple Co., Ltd.
Registration Date : 2016-07-13
Registration Number : 20130121-143-I-209-04(20)
Manufacturer Name : Zhejiang Charioteer Pharmace...
Manufacturer Address : Tongyuanxi, Dazhan, Xianju, Zhejiang Province. P.R. China
Registrant Name : Woojin B&G Co., Ltd.
Registration Date : 2017-02-06
Registration Number : 20130121-143-I-209-04(21)
Manufacturer Name : Zhejiang Charioteer Pharmace...
Manufacturer Address : Tongyuanxi, Dazhan, Xianju, Zhejiang Province. P.R. China
Registrant Name : Myungin Pharmaceutical Co., Ltd.
Registration Date : 2019-02-22
Registration Number : 20130131-143-I-232-05(8)
Manufacturer Name : Divi's Laboratories Limited
Manufacturer Address : Chippada Village, Annavaram Post, Bheemunipatnam Mandal, Visakhapatnam District, Andh...
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2019-01-22
Registration Number : 20130131-143-I-232-05(7)
Manufacturer Name : Divi's Laboratories Limited
Manufacturer Address : Chippada Village, Annavaram Post, Bheemunipatnam Mandal, Visakhapatnam District, Andh...
Registrant Name : Chong Kun Dang Co., Ltd.
Registration Date : 2017-12-08
Registration Number : 20130131-143-I-232-05(5)
Manufacturer Name : Divi's Laboratories Limited
Manufacturer Address : Chippada Village, Annavaram Post, Bheemunipatnam Mandal, Visakhapatnam District, Andh...
Registrant Name : Parmarine Co., Ltd.
Registration Date : 2018-04-25
Registration Number : 20130131-143-I-232-05(6)
Manufacturer Name : Divi's Laboratories Limited.
Manufacturer Address : Chippada Village, Annavaram Post, Bheemunipatnam Mandal, Visakhapatnam District, Andh...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-004
Start Marketing Date : 1997-01-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 30007-815
Start Marketing Date : 2012-02-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-507
Start Marketing Date : 2024-01-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63310-2070
Start Marketing Date : 2005-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63310-2100
Start Marketing Date : 2012-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 62331-002
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-030
Start Marketing Date : 2006-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0129
Start Marketing Date : 1994-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2904
Start Marketing Date : 2010-11-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-4817
Start Marketing Date : 1994-12-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 220MG
Approval Date : 1998-07-28
Application Number : 75168
RX/OTC/DISCN : OTC
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 220MG;120MG
Approval Date : 2006-09-27
Application Number : 77381
RX/OTC/DISCN : OTC
RLD : No
TE Code :
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code :
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 220MG
Approval Date : 2011-09-20
Application Number : 91353
RX/OTC/DISCN : OTC
RLD : No
TE Code :
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code :
DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
Brand Name : NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG;220MG
Approval Date : 2020-09-24
Application Number : 213663
RX/OTC/DISCN : OTC
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 250MG BASE
Approval Date : 1995-05-31
Application Number : 74455
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
Brand Name : ALEVE PM
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG;220MG
Approval Date : 2014-01-17
Application Number : 205352
RX/OTC/DISCN : OTC
RLD : Yes
TE Code :
RLD : No
TE Code :
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 250MG BASE
Approval Date : 1993-08-31
Application Number : 74106
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 220MG
Approval Date : 2022-10-28
Application Number : 211065
RX/OTC/DISCN : OTC
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : NAPROXEN SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 250MG BASE
Approval Date : 1993-12-21
Application Number : 74257
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Esomeprazole Magnesium; Naproxen Sodium
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 20MG; 375MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Packaging :
Regulatory Info : Lead Market Dossiers- Filed
Esomeprazole Magnesium; Naproxen Sodium
Dosage : Oral Solid Dosage Form
Dosage Strength : 20MG; 375MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Esomeprazole Magnesium; Naproxen Sodium
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 20MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Packaging :
Regulatory Info : Lead Market Dossiers- Filed
Esomeprazole Magnesium; Naproxen Sodium
Dosage : Oral Solid Dosage Form
Dosage Strength : 20MG; 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Naproxen Sodium
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 250MG
Brand Name : Naproxen Sodium
Approval Date :
Application Number :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Naproxen Sodium
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 500MG
Brand Name : Naproxen Sodium
Approval Date :
Application Number :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Naproxen Sodium
Dosage Form : Soft Gel Capsule
Dosage Strength : 220MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Packaging :
Regulatory Info :
Dosage : Soft Gel Capsule
Dosage Strength : 220MG
Brand Name : Naproxen Sodium
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Naproxen Sodium
Dosage Form : Immediate Release Tabl...
Dosage Strength : 220MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 220MG
Brand Name : Naproxen Sodium
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Naproxen Sodium
Dosage Form :
Dosage Strength : 73.3%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage :
Dosage Strength : 73.3%
Brand Name : Naproxen Sodium
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : BILAYERED TABLET
Dosage Strength : 50MG; 275MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Soft Gel
Dosage Strength : 220MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Soft Gel
Dosage Strength : 220MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Turkey
Brand Name : Synax
Dosage Form : FC Tablet
Dosage Strength : 550MG
Packaging : 10 Film Coated Tablet / Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 10 Film Coated Tablet / Box
Regulatory Info :
Dosage : FC Tablet
Dosage Strength : 550MG
Brand Name : Synax
Approval Date :
Application Number :
Registration Country : Turkey
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - EQ 250MG BASE **Federa...DOSAGE - TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 18164
DOSAGE - TABLET;ORAL - EQ 500MG BASE
USFDA APPLICATION NUMBER - 18164
DOSAGE - TABLET;ORAL - 220MG
USFDA APPLICATION NUMBER - 20204
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 3...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 375MG BASE
USFDA APPLICATION NUMBER - 20353
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 5...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 500MG BASE
USFDA APPLICATION NUMBER - 20353
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 7...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 750MG BASE
USFDA APPLICATION NUMBER - 20353
DOSAGE - CAPSULE;ORAL - EQ 200MG BASE
USFDA APPLICATION NUMBER - 21920
DOSAGE - TABLET;ORAL - 500MG;EQ 85MG BASE
USFDA APPLICATION NUMBER - 21926
DOSAGE - TABLET;ORAL - 60MG;EQ 10MG BASE
USFDA APPLICATION NUMBER - 21926
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vertellus
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Thickeners and Stabilizers
Disintegrants & Superdisintegrants
Controlled & Modified Release
Solubilizers
Direct Compression
Granulation
Parenteral
Film Formers & Plasticizers
Taste Masking
Topical
Lubricants & Glidants
Chewable & Orodispersible Aids
Co-Processed Excipients
Rheology Modifiers
Empty Capsules
Emulsifying Agents
API Stability Enhancers
Surfactant & Foaming Agents
Coloring Agents
Vegetarian Capsules
Soft Gelatin
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
84
PharmaCompass offers a list of Naproxen Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Naproxen Sodium manufacturer or Naproxen Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naproxen Sodium manufacturer or Naproxen Sodium supplier.
PharmaCompass also assists you with knowing the Naproxen Sodium API Price utilized in the formulation of products. Naproxen Sodium API Price is not always fixed or binding as the Naproxen Sodium Price is obtained through a variety of data sources. The Naproxen Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, including repackagers and relabelers. The FDA regulates NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE supplier is an individual or a company that provides NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE active pharmaceutical ingredient (API) or NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE finished formulations upon request. The NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE suppliers may include NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE API manufacturers, exporters, distributors and traders.
click here to find a list of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE DMF (Drug Master File) is a document detailing the whole manufacturing process of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE active pharmaceutical ingredient (API) in detail. Different forms of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE DMFs exist exist since differing nations have different regulations, such as NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE DMF submitted to regulatory agencies in the US is known as a USDMF. NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE USDMF includes data on NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE Drug Master File in Korea (NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE. The MFDS reviews the NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE KDMF as part of the drug registration process and uses the information provided in the NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE KDMF to evaluate the safety and efficacy of the drug.
After submitting a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE suppliers with KDMF on PharmaCompass.
A NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CEP of the European Pharmacopoeia monograph is often referred to as a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE Certificate of Suitability (COS). The purpose of a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE to their clients by showing that a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CEP has been issued for it. The manufacturer submits a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CEP (COS) as part of the market authorization procedure, and it takes on the role of a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CEP holder for the record. Additionally, the data presented in the NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE DMF.
A NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE suppliers with CEP (COS) on PharmaCompass.
A NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE written confirmation (NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE WC) is an official document issued by a regulatory agency to a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE manufacturer, verifying that the manufacturing facility of a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE APIs or NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE finished pharmaceutical products to another nation, regulatory agencies frequently require a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE WC (written confirmation) as part of the regulatory process.
click here to find a list of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE suppliers with NDC on PharmaCompass.
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE GMP manufacturer or NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE GMP API supplier for your needs.
A NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CoA (Certificate of Analysis) is a formal document that attests to NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE's compliance with NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE specifications and serves as a tool for batch-level quality control.
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CoA mostly includes findings from lab analyses of a specific batch. For each NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE may be tested according to a variety of international standards, such as European Pharmacopoeia (NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE EP), NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE USP).
